| Christopher Chin, MD | |
|
701 E El Camino Real, Mountain View, CA 94040-2833 | |
| (650) 404-8370 | |
| Not Available |
| Full Name | Christopher Chin |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 701 E El Camino Real, Mountain View, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194776401 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A70757 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.
The Fairbanks Institute for Healthy Communities, the Indianapolis not-for-profit organization working to improve community health, and BioServe, a global provider of biomaterial and genetic research services, today announced that they will co-market INbank™, a next generation biorepository that was recently launched by The Fairbanks Institute.
Results of a new study published in the current issue of the New England Journal of Medicine show that in patients who have chronic hepatitis C, genotype 1 - the most common form of the disease and difficult to treat successfully - non-Hispanic whites achieved one of the highest response rates reported to date, but response rates in African Americans were significantly lower.
› Verified 8 days ago
| Entity Name | Sutter Bay Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.
The Fairbanks Institute for Healthy Communities, the Indianapolis not-for-profit organization working to improve community health, and BioServe, a global provider of biomaterial and genetic research services, today announced that they will co-market INbank™, a next generation biorepository that was recently launched by The Fairbanks Institute.
Results of a new study published in the current issue of the New England Journal of Medicine show that in patients who have chronic hepatitis C, genotype 1 - the most common form of the disease and difficult to treat successfully - non-Hispanic whites achieved one of the highest response rates reported to date, but response rates in African Americans were significantly lower.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Chin, MD 2350 W El Camino Real, 2nd Floor, Mountain View, CA 94040-6201 Ph: () - | Christopher Chin, MD 701 E El Camino Real, Mountain View, CA 94040-2833 Ph: (650) 404-8370 |
News Archive
Cempra Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases,today announced that data will be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), in London, March 31 to April 3,demonstrating CEM-101's (solithromycin's) efficacy to be comparable to levofloxacin in a Phase 2 trial of patients with community-acquired bacterial infections.
RedHill Biopharma Ltd., a specialty pharma company that is a leader in the development of novel oral therapies for COVID-19, today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640) in patients hospitalized with severe COVID-19 pneumonia (NCT04467840). Top-line results are expected in the coming weeks.
The Fairbanks Institute for Healthy Communities, the Indianapolis not-for-profit organization working to improve community health, and BioServe, a global provider of biomaterial and genetic research services, today announced that they will co-market INbank™, a next generation biorepository that was recently launched by The Fairbanks Institute.
Results of a new study published in the current issue of the New England Journal of Medicine show that in patients who have chronic hepatitis C, genotype 1 - the most common form of the disease and difficult to treat successfully - non-Hispanic whites achieved one of the highest response rates reported to date, but response rates in African Americans were significantly lower.
› Verified 8 days ago
Timothy Nieh, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-404-8370 | |
Stuart Menaker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-404-8370 | |
Satya Chelamkuri, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: El Camino Hospital, 2500 Grant Road, Mountain View, CA 94040 Phone: 585-208-7373 | |
Lianghuey Leu, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 555 Castro St, Mountain View, CA 94041 Phone: 650-903-3020 | |
Dr. William Le, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E El Camino Real, Mountain View, CA 94040 Phone: 650-934-7808 | |
Christine P. Weigen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 225 San Antonio Rd, Mountain View, CA 94040 Phone: 650-948-0807 Fax: 650-948-3319 | |
Roushig Kalebjian, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 565 San Antonio Rd, Mountain View, CA 94040 Phone: 650-941-7170 |